ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,774 | -16.8% | 38,258 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $137,999 | +11.9% | 36,898 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $123,367 | -28.9% | 36,826 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $173,607 | -15.7% | 36,093 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $206,000 | -18.9% | 36,224 | +1.4% | 0.00% | -50.0% |
| Q2 2022 | $254,000 | +9.5% | 35,712 | +11.4% | 0.00% | +100.0% |
| Q1 2022 | $232,000 | -24.4% | 32,065 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $307,000 | -75.2% | 34,322 | -2.9% | 0.00% | -71.4% |
| Q3 2021 | $1,239,000 | +59.5% | 35,349 | -2.3% | 0.01% | +133.3% |
| Q2 2021 | $777,000 | +48.9% | 36,189 | +328.2% | 0.00% | +50.0% |
| Q1 2021 | $522,000 | +48.3% | 8,452 | +0.3% | 0.00% | +100.0% |
| Q4 2020 | $352,000 | – | 8,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |